![Mutant T Cells That Drive Amyotrophic Lateral Sclerosis (ALS) Progression May React To a Brain Antigen | The Scientist Magazine® Mutant T Cells That Drive Amyotrophic Lateral Sclerosis (ALS) Progression May React To a Brain Antigen | The Scientist Magazine®](https://cdn.the-scientist.com/assets/articleNo/70310/aImg/47065/istock-1289585626-800x560-l.jpg)
Mutant T Cells That Drive Amyotrophic Lateral Sclerosis (ALS) Progression May React To a Brain Antigen | The Scientist Magazine®
![Biomedicines | Free Full-Text | Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy Biomedicines | Free Full-Text | Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy](https://www.mdpi.com/biomedicines/biomedicines-11-02967/article_deploy/html/images/biomedicines-11-02967-g001.png)
Biomedicines | Free Full-Text | Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
![Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges | Translational Neurodegeneration | Full Text Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges | Translational Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40035-023-00377-7/MediaObjects/40035_2023_377_Fig2_HTML.png)
Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges | Translational Neurodegeneration | Full Text
![IJMS | Free Full-Text | Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics? IJMS | Free Full-Text | Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?](https://www.mdpi.com/ijms/ijms-23-09364/article_deploy/html/images/ijms-23-09364-g001.png)
IJMS | Free Full-Text | Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
![Frontiers | Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability Frontiers | Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability](https://www.frontiersin.org/files/Articles/605335/fneur-11-605335-HTML/image_m/fneur-11-605335-g001.jpg)
Frontiers | Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability
![IJMS | Free Full-Text | Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis IJMS | Free Full-Text | Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis](https://www.mdpi.com/ijms/ijms-24-00704/article_deploy/html/images/ijms-24-00704-g001.png)
IJMS | Free Full-Text | Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis
![Genes | Free Full-Text | Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis Genes | Free Full-Text | Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis](https://www.mdpi.com/genes/genes-08-00060/article_deploy/html/images/genes-08-00060-g001.png)
Genes | Free Full-Text | Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis
![IJMS | Free Full-Text | RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective IJMS | Free Full-Text | RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective](https://www.mdpi.com/ijms/ijms-22-10285/article_deploy/html/images/ijms-22-10285-g001.png)
IJMS | Free Full-Text | RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
![Antioxidants | Free Full-Text | Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis Antioxidants | Free Full-Text | Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis](https://www.mdpi.com/antioxidants/antioxidants-12-01747/article_deploy/html/images/antioxidants-12-01747-g001.png)
Antioxidants | Free Full-Text | Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
![Frontiers | Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications Frontiers | Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications](https://www.frontiersin.org/files/MyHome%20Article%20Library/1131758/1131758_Thumb_400.jpg)
Frontiers | Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications
![Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy | Journal of Human Genetics Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy | Journal of Human Genetics](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs10038-022-01055-8/MediaObjects/10038_2022_1055_Fig2_HTML.png)
Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy | Journal of Human Genetics
![Cells | Free Full-Text | Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy Cells | Free Full-Text | Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy](https://pub.mdpi-res.com/cells/cells-12-01948/article_deploy/html/images/cells-12-01948-g001-550.jpg?1690444596)